Clinical trial

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

NCT00987220

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-10-01

PhaseN/A

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2011-02-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Dementiaunresolved

Interventions

PlaceboDRUG

donepezil (Aricept)DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00987220 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.